Events & Presentations

Presentation

Upcoming Events

More events are coming soon.

Past Events

Date Event Details
December 5, 2019
1:30 PM EST
December 3, 2019
8:30 AM EST
November 20, 2019
2:25 PM EST
October 2, 2019
2:25 PM EDT
September 10, 2019
9:10 AM EDT
June 25, 2019
3:40 PM EDT
June 7, 2019
10:00 AM PDT
101 California Street,
Fifth Floor,
San Francisco, CA 94010
May 18 - May 21, 2019
Title: The Oral α4β7 Integrin Specific Antagonist PN-10943 is More Effective Than PTG 100 in Multiple Preclinical Studies
Presenting Author: Larry Mattheakis, PhD, Sr. VP, Discovery Biology and Translational Research
 
May 8, 2019
8:30 AM EDT
April 9, 2019
9:50 a.m. BST
March 12, 2019
4:30 PM EDT
February 28, 2019
9:00 AM EST
December 12, 2018
9:20 AM EST
November 27, 2018
4:30 PM EST
October 20, 2018 12:00 PM EDT through
October 24, 2018 11:59 PM EDT

Presentation Title: PTG-100, an oral gut-restricted peptide alpha-4-beta-7 antagonist induces clinical and histologic remission in patients with moderate to severely active ulcerative colitis
Date and Time: Monday, October 22 from 14:00 to 15:30 CEST
Session: Room C – Clinical trials in IBD
Location: ACV, Vienna, Austria

September 24, 2018
7:00 AM EDT
Event date, time and location: October 1, 2018 at 4:40 PM EDT at the InterContinental New York Barclay Hotel
August 6, 2018
8:00 AM EDT
June 20, 2018
2:00 PM EDT
June 14, 2018 12:00 PM CEST through
June 17, 2018 11:59 PM CEST
Presentation Title: Hepcidin mimetic PTG-300 for treatment of ineffective erythropoiesis and chronic anemia in hemoglobinopathy diseases
Date and Time: Saturday, June 16 from 11:45 AM to 12:00 PM CEST
Session: Thalassemias
Location: Stockholm International Fairs Convention Center, Room K2

Presentation Title: Hepcidin Mimetic PTG-300 induces dose-related and sustained reductions in serum iron and transferrin saturation in healthy subjects
Date and Time: Saturday, June 16 from 5:00 PM to 5:15 PM CEST
Session: Iron metabolism, deficiency and overload
Location: Stockholm International Fairs Convention Center, Room A13
Stockholm, Sweden

Stockholm International Fairs
125 30 Stockholm
Sweden

June 2, 2018
12:00 PM EDT
Presentation Title: Oral delivery of peptides with dual mu/delta opioid receptor agonist activities are superior to eluxadoline in preclinical models of IBS-D
Date and Time: Saturday, June 2 from 5:00 PM to 5:15 PM ET
Session: Diarrhea and Irritable Bowel Syndrome - New Advances
Location: Washington Convention Center, Room 140
Presenting author: Larry Mattheakis, Vice President of Biology, Protagonist Therapeutics, Inc.
Walter E. Washington Convention Center in Washington, D.C.

United States

May 29, 2018
11:00 AM PDT
Conference Center
Pacific Research Center
7677 Gateway Blvd.
Newark, California 94560
March 26, 2018
8:00 AM EDT
March 21, 2018
3:20 PM EDT
The Westin New York Grand Central hotel in New York, NY

United States

March 15, 2018
11:15 AM EDT
March 7, 2018
4:30 PM EST
February 26 - March 2, 2018

Location:

Snowbird, UT
United States

February 14, 2018
9:30 AM EST
Lotte New York Palace in New York, NY

United States

December 14, 2017
8:00 AM EST
Westin Grand Central Hotel, New York, NY

United States

November 15, 2017
10:15 AM EST
Lotte New York Palace Hotel in New York, NY

United States

September 26, 2017
8:35 AM EDT
InterContinental New York Barclay Hotel

New York, NY
United States

May 30, 2017
8:00 AM EDT
Event date and time: May 30, 2017 at 8:00 AM EDT
Webcast link: http://edge.media-server.com/m/p/bbh32fun
Teleconference details: toll-free 844-515-9178 or toll call +1-614-999-9313, conference ID number 30341699
May 25, 2017
10:00 AM PDT
Conference Center
Pacific Research Center
7677 Gateway Blvd.
Newark, CA 94560
May 6, 2017 12:00 PM EDT through
May 9, 2017 11:59 PM EDT
Presentation Title: The Biomarker Profile of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor, Tracks with Efficacy in a Preclinical Model of IBD
Date and Time: Saturday, May 6 from 11:15 AM to 11:30 AM CT
Location: McCormick Place, Room S102d
Chicago, Illinois

United States

April 24, 2017 12:00 PM EDT through
April 25, 2017 11:59 PM EDT
Session: Advances in Peptide Therapeutics
Presentation: Discovery & Development of PTG-100, an Oral Peptide Antagonist of α4β7 Integrin, in Clinical Development for the Treatment of Inflammatory Bowel Disease
Presenter: Ashok Bandari, Ph.D., Vice President, Chemistry, Protagonist Therapeutics
Date and Time: 9-9:30 AM BST, Tuesday April 25
Room: Conference Room 3- Epernay
London, UK, Novotel London West

United States

April 23, 2017 12:00 PM EDT through
April 27, 2017 11:59 PM EDT

Presentation: Biomarker Discovery and Development of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor
Meeting: 8th Annual Inflammation Inhibitors: Small Molecule Approaches for Oral-based Therapeutics
Presenter: Larry Mattheakis, Ph.D., Vice President, Biology, Protagonist Therapeutics Date and Time: 10:35 am PT, Monday April 24

Presentation: Discovery & Development of PTG-100, an Oral Peptide Antagonist of α4β7 Integrin, for the Treatment of Inflammatory Bowel Disease
Meeting: 5th Annual Macrocyclics and Constrained Peptides: Bigger, Better and Still Oral Small Molecules
Presenter: Ashok Bandari, Ph.D., Vice President, Chemistry, Protagonist Therapeutics Date and Time: 2:20 PM PT, Wednesday April 26

San Diego, CA, Sheraton San Diego Hotel and Marina

United States

March 21, 2017
2:10 PM EDT
Westin New York Grand Central hotel, New York, NY.

United States

March 14, 2017
2:05 PM EDT
Presenting: Dinesh V. Patel, Ph.D., Protagonist President and Chief Executive Officer
Miami, FL, Loews Miami Beach Hotel

United States

February 16, 2017
11:00 AM EST
Presenting: Dinesh V. Patel, Ph.D., Protagonist President and Chief Executive Officer
New York, NY, Lotte New York Palace

United States

February 15, 2017 12:00 PM EST through
February 18, 2017 11:59 PM EST
Poster Number: P113
Poster Title: Model based predictions of the PTG-100 pharmacodynamic responses in Ulcerative Colitis patients
Date and Time: February 17, 2017 12:30-13:30
Presenting Author: Larry Mattheakis


Poster Number: P001
Poster Title: The Biomarker Profile of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor, Tracks with Efficacy in a Preclinical Model of IBD
Date and Time: February 17, 2017 12:30-13:30
Presenting Author: Lili Cheng
Barcelona, Spain

United States

December 14, 2016
2:20 PM EST

New York, NY
United States

December 8, 2016 12:00 PM EST through
December 9, 2016 11:59 PM EST
Poster Number: P-271
Poster Title: The Biomarker Profile of PTG-200, An Oral Peptide Antagonist of IL-23 Receptor, Correlates with Efficacy in Preclinical Models of IBD
Date and Time: Friday, December 9, 2016 06:00 PM - 07:00 PM ET
Poster Location: Exhibit Hall - Atlantic B-C

Orlando, FL
United States

November 7, 2016 12:00 PM EST through
November 9, 2016 11:59 PM EST
Cologne Germany

United States

October 15, 2016 12:00 PM EDT through
October 19, 2016 11:59 PM EDT
Poster Number: P0298
Poster Title: Safety, Pharmacokinetics and Pharmacodynamics of the Novel Oral Peptide Therapeutic PTG-100 (alpha4-beta7 Integrin Antagonist) in Normal Healthy Volunteers
Date and Time: Monday October 17, 10:30 - 17:00, presentation 12:30 - 13:30 CET
Presenting Author: Richard S. Shames, MD, Protagonist Chief Medical Officer


Poster Number: P0792
Poster Title: Pharmacokinetics and Pharmacodynamics Following Oral Administration of PTG-100, a Peptide Antagonist of Integrin alpha4-beta7
Date and Time: Tuesday October 18, 9:00 to 17:00, presentation 12:30 - 13:30 CET
Presenting Author: Thamil Annamalai, M.S., Protagonist Senior Director, Preclinical Development
Vienna Austria

United States

August 23, 2016
10:00 AM EDT
Philadelphia, PA

United States